{"id":25408,"date":"2026-05-28T15:29:21","date_gmt":"2026-05-28T13:29:21","guid":{"rendered":"https:\/\/adragos-pharma.com\/?p=25408"},"modified":"2026-05-28T15:29:22","modified_gmt":"2026-05-28T13:29:22","slug":"adragos-pharma-at-the-14th-antibody-industrial-symposium-ais2026-montpellier-france","status":"publish","type":"post","link":"https:\/\/adragos-pharma.com\/adragos-pharma-at-the-14th-antibody-industrial-symposium-ais2026-montpellier-france\/","title":{"rendered":"Adragos Pharma at the 14th Antibody Industrial Symposium (AIS2026) \u2014 Montpellier, France"},"content":{"rendered":"<p><!-- \n  =============================================\n  ADRAGOS PHARMA \u2013 AIS2026 EVENT PAGE\n  WordPress Block Editor (Copy-paste ready)\n  =============================================\n  SEO Target Keywords:\n  - AIS2026 \/ AIS 2026\n  - 14th Antibody Industrial Symposium\n  - CDMO biologics\n  - antibody fill and finish\n  - biologics contract manufacturing\n  - aseptic fill finish CDMO\n  - Montpellier pharma event\n  =============================================\n--><\/p>\n\n\n<p class=\"wp-block-paragraph\">Adragos Pharma is pleased to confirm its participation in the <strong>14th Antibody Industrial Symposium (AIS2026)<\/strong>, taking place in <strong>Montpellier, France<\/strong>. Organised by <strong>MabDesign<\/strong> and <strong>MabImprove<\/strong>, AIS2026 brings together leading players across the antibody and biologics value chain \u2014 from discovery through to commercial manufacturing. As a European <strong>Contract Development and Manufacturing Organisation (CDMO)<\/strong> with dedicated <strong>aseptic fill-and-finish capabilities for biological products<\/strong>, we look forward to connecting with biotech innovators, pharmaceutical companies, and industry partners at this year&#8217;s symposium.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Biologics Capabilities Built for the Antibody Industry<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The antibody landscape demands manufacturing partners who understand the complexity of <strong>biologic drug products<\/strong> \u2014 from formulation development and clinical supply through to commercial-scale production. Adragos Pharma offers a strong European footprint with <strong>GMP-certified facilities<\/strong> purpose-built for sterile and aseptic manufacturing:<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u2714 <strong>Aseptic fill-and-finish for biologics and small molecules<\/strong> \u2014 liquid and lyophilised vials for clinical trial and commercial supply (Jura, Switzerland)<br>\u2714 <strong>Prefilled syringes, liquid and lyophilised vials<\/strong> \u2014 advanced aseptic filling, freeze-drying, and inspection systems (Maisons-Alfort, France)<br>\u2714 <strong>End-to-end CDMO services<\/strong> \u2014 from drug development and tech transfer to lifecycle management and commercial manufacturing<br>\u2714 <strong>Regulatory-ready, scalable processes<\/strong> \u2014 designed for the quality and compliance standards the biologics sector requires<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Why Partner with Adragos Pharma for Antibody Manufacturing?<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">At Adragos Pharma, we combine <strong>multinational operational strength with personalised service<\/strong>. Our 7 GMP facilities across the EU, US, and Japan allow us to offer local insights and tailored solutions \u2014 because we know that one size does not fit all. From <strong>early-stage clinical supply<\/strong> through to <strong>full-scale commercial production<\/strong>, we invest in the success of your product beyond standard timelines.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Our established presence in <strong>Japan \u2014 the world&#8217;s most demanding pharmaceutical market<\/strong> \u2014 reflects our commitment to quality, adaptability, and long-term partnership.<\/p>\n\n\n\n<section class=\"wp-block-adragos-blocks-image-text max-w-screen-lg mx-auto grid grid-cols-1 md:grid-cols-2 md:gap-20 items-center\"><div><img decoding=\"async\" class=\"main-image\" src=\"https:\/\/adragos-pharma.com\/wp-content\/uploads\/2025\/06\/nancy-1.jpeg\" alt=\"Person \"\/><\/div><div class=\"relative my-6\">\n<h2 class=\"wp-block-heading has-secondary-color has-text-color has-link-color wp-elements-731c6fa98638da5659e7ae281290569f\">Meet Our Team<\/h2>\n\n\n\n<h3 class=\"wp-block-heading\">Nancy Martinez<br>Senior Business Development Manager<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Nancy brings a strong scientific background in biologics, CDMO services, and clinical project management to every conversation. With previous key roles at GTP Bioways and Pierre Fabre, she has supported innovative biotech and pharma projects across Europe. Her expertise spans antibody development, aseptic fill &amp; finish, client relationship management, and strategic sales \u2014 offering a unique combination of technical insight and commercial acumen to partners in the life sciences industry.<\/p>\n<\/div><\/section>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>About the 14th Antibody Industrial Symposium (AIS2026)<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">The <strong>Antibody Industrial Symposium<\/strong>, organised by <strong>MabDesign<\/strong> and <strong>MabImprove<\/strong>, is one of the premier European events dedicated to the <strong>antibody and therapeutic protein industry<\/strong>. AIS2026 brings together researchers, CDMOs, biotech companies, and pharmaceutical leaders for scientific presentations, partnering sessions, and networking \u2014 all focused on advancing the antibody sector from discovery to patient.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Connect with Us in Montpellier<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Our team will be attending <strong>AIS2026<\/strong> in Montpellier, and we welcome the opportunity to discuss your <strong>biologics manufacturing needs<\/strong>, explore potential collaborations, and share how Adragos Pharma can support your antibody pipeline \u2014 from clinical-stage fill-and-finish through to commercial supply.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\ud83d\udcc5 <strong>June 30- July 1st<\/strong><br>\ud83d\udccd <strong>Montpellier, France<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">We look forward to meeting you and exploring new opportunities to advance <strong>antibody development and manufacturing<\/strong> together.<\/p>\n\n\n\n<section class=\"wp-block-adragos-blocks-footer-cta max-w-screen-lg bg-light mx-8 md:mx-auto px-8 py-12 text-center mt-3 mb-12 md:mb-16 rounded-xl\"><h2 class=\"\">Looking forward to meeting you at AIS2026<\/h2><p class=\"subtitle font-light m-auto max-w-screen-sm py-6\">Interested in discussing your biologics project with our team? We would love to have a chat. Please fill out our contact form or reach out to schedule a meeting at the event.<\/p><div class=\"flex flex-col md:flex-row justify-center gap-4\"><a href=\"https:\/\/adragos-pharma.com\/contact-us\/?utm_campaign=AIS2026&amp;utm_source=blog&amp;utm_medium=organic_search\" class=\"cta-link inline-block adragos-button text-white has-primary-background-color text-center\">&lt;a href=&#8221;https:\/\/adragos-pharma.com\/contact-us\/&#8221; data-type=&#8221;link&#8221; data-id=&#8221;https:\/\/adragos-pharma.com\/contact-us\/&#8221;>Contact us&lt;\/a><\/a><\/div><\/section>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Adragos Pharma is pleased to confirm its participation in the 14th Antibody Industrial Symposium (AIS2026), taking place in Montpellier, France. Organised by MabDesign and MabImprove, AIS2026 brings together leading players across the antibody and biologics value chain \u2014 from discovery [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":25409,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","inline_featured_image":false,"footnotes":""},"categories":[17],"tags":[],"topics":[],"locations":[],"experts":[],"class_list":["post-25408","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-events"],"_links":{"self":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/25408","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/comments?post=25408"}],"version-history":[{"count":1,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/25408\/revisions"}],"predecessor-version":[{"id":25416,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/posts\/25408\/revisions\/25416"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media\/25409"}],"wp:attachment":[{"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/media?parent=25408"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/categories?post=25408"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/tags?post=25408"},{"taxonomy":"topics","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/topics?post=25408"},{"taxonomy":"locations","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/locations?post=25408"},{"taxonomy":"experts","embeddable":true,"href":"https:\/\/adragos-pharma.com\/wp-json\/wp\/v2\/experts?post=25408"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}